Long Xie

Dr. Long Xie

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LXLong Xie
Long Xie
WXWeiwei Xiao
Weiwei Xiao
HFHangqi Fang
Hangqi Fang
GLGuoqiang Liu
Guoqiang Liu
Receptor activity modifying protein 1 (RAMP1) facilitates the localization of the calcitonin-like receptor (CLR) to the plasma membrane, but its role in osteosarcoma (OS) remains unclear. We evaluated the RAMP1 expression and prognostic value across different cancers, studying tumor immune infiltration. The prognostic value was analyzed using the GSE39058 and TARGET datasets. Differential gene expression was evaluated. a protein-protein interaction network was constructed, and gene set enrichment analysis was performed. The function of RAMP1 in the tumor microenvironment was analyzed, and its expression in OS cell lines was validated using quantitative real-time PCR. High RAMP1 expression correlated with poor prognosis relative to low RAMP1 expression (p < 0.05). Low RAMP1 expression correlated with an abundance of CD4+ memory-activated T cells. whereas a high expression level correlated with a high proportion of gamma-delta T cells (γδ T cells). Differentially expressed genes from TARGET was enriched in olfactory transduction pathways (normalized enrichment scores [NES] = 1.6998, p < 0.0001). RAMP1 expression negatively correlated with CD44 expression but positively correlated with TNFSF9 expression. The RAMP1 gene is substantially expressed in OS cells compared to the normal osteoblast cell line hFOB1.19. Thus, RAMP1 may be a prognostic biomarker and potential therapeutic target in OS.

26 November 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
LXLong Xie
Long Xie
WYWenhua Yin
Wenhua Yin
FTFuxing Tang
Fuxing Tang
MHMao Lin He
Mao Lin He
To investigate the possible functions of TERT in pan-cancer and OS. First, differential TERT gene expression analysis was conducted using multi-omics data integrative analyses, including differential expression, prognosis, the correlation between infiltrating inflammatory immune cells, and mutation in pan-cancer. Furthermore, differential TERT gene expression analysis was conducted using mRNA expression profiles related to OS based on the GEO Datasets. Various differentially expressed genes were chosen based on a fitness threshold for further investigations. Finally, the function of the TERT gene was assessed in OS cells, including cellular proliferation, migration, and metastasis. Pan-cancer research demonstrated that variable expression of TERT was not only associated with numerous types of human cancer but was also intimately linked to DNA methylation. Bioinformatic investigation revealed a link between the differential expression of TERT with immune cell infiltration in the tumor microenvironment (TME). In vitro studies indicated that inhibition of TERT decreased OS cell proliferation, motility, and metastasis. TERT may serve as a useful genomic biomarker for the diagnosis and prediction of pan-cancer and as a prospective therapeutic target for the treatment of OS.

29 April 2025 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
LXLong Xie
Long Xie
YPYu Qin Peng
Yu Qin Peng
XSXiang Shen
Xiang Shen
The treatment and prevention of diabetic retinopathy (DR) remain significant challenges. Mendelian randomization (MR) has been widely used to explore novel therapeutic targets. In this study, we conducted a systematic druggable genome-wide MR analysis to explore potential therapeutic targets for DR. We obtained data on druggable genes and screened for genes within blood expression quantitative trait loci (eQTL), which were then subjected to MR analysis and colocalization analysis with DR genome-wide association studies data to identify genes strongly associated with DR. Additionally, Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, protein-protein interaction (PPI) network construction, drug candidate prediction, and molecular docking were performed to provide valuable insights for the development of more effective and targeted therapeutic drugs. MR analysis of blood eQTLs revealed 30 significant DR-associated druggable genes, with PRKAB1 (OR = 0.935, 95% CI: 0.892 to 0.980) and CNR1 (OR = 0.814, 95% CI: 0.696 to 0.951) being protective genes, whereas CACNA1E (OR = 1.282, 95% CI: 1.050 to 1.565), NME1 (OR = 1.198, 95% CI: 1.028 to 1.397), and CHRNA2 (OR = 1.192, 95% CI: 1.025 to 1.386) were associated with increased risk. KEGG analysis highlighted significant pathways, including adrenergic signaling in cardiomyocytes (hsa04261), the oxytocin signaling pathway (hsa04921), and arrhythmogenic right ventricular cardiomyopathy (hsa05412). PPI network analysis identified two key modules: one comprising BIN1, CDH2, ACTN1, EPAS1, CEBPA, and CTSD nodes, and the other consisting of CACNG6, CACNA1E, CACNA2D3, and RASGRP3 nodes. Drug candidate prediction suggested ethanol and isoflupredone as potential therapeutic interventions, and molecular docking revealed C5’s strong protein binding affinity. This study utilized MR and colocalization analysis to identify potential drug targets for DR. The findings provide promising leads for the treatments of DR, potentially reducing drug development costs.

10 July 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
LXLong Xie
Long Xie
WGWen Gan
Wen Gan
GCGuangRong Cai
GuangRong Cai
Background: Many studies suggest a strong correlation between gut microbiota (GM) and diabetic neuropathy (DN). However, the precise causal relationship between GM and DN has yet to be fully elucidated. Hence, a bi-directional Mendelian randomization (MR) analysis was used to examine the association between GM and DN.Methods: Widely known genome-wide association study (GWAS) of GM was collected from the MiBio Gen project. Summary-level datasets for DN were taken from the FinnGen project. Inverse variance weighted approach was used for evaluating the causal relationship between GM and DN. Subsequently, pleiotropy and heterogeneity tests were performed to verify the reliability of the data. Furthermore, a bidirectional two-sample MR analysis was done to investigate the directionality of the causal relationships. Gene Ontology analysis was conducted to identify the associations that could indicate biological functions.Results: We identified potential causal associations between GM and DN (p< 0.05 in all three MR methods). Among them, we found increased levels of Christensenellaceae R-7 (Odds ratio, OR= 1.52; 95% confidence interval, CI = 1.03–2.23; p = 0.03), Ruminococcaceae UCG013 (OR =1.35; 95% CI = 1.00–1.85; p = 0.04), and Eggerthella groups (OR = 1.27; 95% CI = 1.05–1.55; p = 0.01), which may be associated with a higher risk of DN, while increased levels of Peptococcaceae (OR = 0.69; 95% CI = 0.54–0.90; p< 0.01) and Eubacterium coprostanoligenes groups (OR = 0.68; 95% CI = 0.49–0.93; p = 0.01) could be associated with a lower risk. Gene Ontology pathway analysis revealed enrichment of genes regulated by the associated single-nucleotide polymorphisms (SNPs) in the apical plasma membrane, glycosyltransferase activity, hexosyltransferase activity and membrane raft. Reverse MR analyses indicated that DN was associated with five microbial taxa in all three MR methods.Conclusion: The results of our study validate the possible causative relationship between GM and DN. This discovery gives new perspectives into the mechanism on how GM influences DN, and establishes a theoretical foundation for future investigations into targeted preventive measures.

29 October 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
LXLong Xie
Long Xie
YPYu Qin Peng
Yu Qin Peng
WWWei Qiang Wei
Wei Qiang Wei
XSXiang Shen
Xiang Shen
Life’s Essential 8 (LE8) is a comprehensive cardiovascular health (CVH) metric that is associated with chronic diseases. This study aimed to investigate the association between LE8 and diabetic retinopathy (DR) and the mediating role of depression in this association. We analyzed cross-sectional data from 3,815 adults with diabetes mellitus from the National Health and Nutrition Examination Survey (NHANES) (1999–2020). LE8 scores (0–100) were calculated based on diet, physical activity, nicotine exposure, sleep health, body mass index (BMI), blood lipid levels, blood glucose levels, and blood pressure. DR was diagnosed using retinal imaging or self-reports. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Weighted logistic regression and mediation analysis were performed. In addition, machine learning (Shapley additive explanation [SHAP]) was used to explain the importance ranking of variables. Weighted logistic regression models revealed a significant negative association between LE8 scores and the risk of DR. The LE8 score had strong, dose-dependent protective effects against DR, with each 10-point increase in the score being associated with a 2% reduction in the risk of DR (odds ratio [OR] = 0.98, P < 0.0001) across adjusted models. A threshold effect was observed at the LE8 score of 73.12. The protective effect of the LE8 score was significant below this threshold (OR1 = 0.98, P < 0.0001), whereas it was diminished above this threshold (OR2 = 1.06, P = 0.097). Mediation analysis indicated that PHQ-9 scores mediated 13.66% of the total effect of LE8 (P < 0.0001). SHAP analysis showed that blood glucose levels (35.5% importance) had the greatest impact on risk prediction, followed by modifiable behaviors such as physical activity (18.0%) and sleep health (13.5%). LE8 scores are negatively associated with the risk of DR in US adults with diabetes mellitus, and this association is partially mediated by depressive symptoms. Longitudinal studies are warranted to validate causality and elucidate the underlying mechanisms. Interventions targeting both metabolic and mental health may reduce the disease burden of DR.

2 August 2023 in Research Square
Verified
Preprint
Open access
PDF file
LXLong Xie
Long Xie
WXWeiwei Xiao
Weiwei Xiao
HFHangqi Fang
Hangqi Fang
GLGuoqiang Liu
Guoqiang Liu
Receptor activity modifying protein 1 (RAMP1) facilitates the localization of the calcitonin-like receptor (CLR) to the plasma membrane, but its role in osteosarcoma (OS) remains unclear. We evaluated the RAMP1 expression and prognostic value across different cancers, studying tumor immune infiltration. The prognostic value was analyzed using the GSE39058 and TARGET datasets. Differential gene expression was evaluated. a protein-protein interaction network was constructed, and gene set enrichment analysis was performed. The function of RAMP1 in the tumor microenvironment was analyzed, and its expression in OS cell lines was validated using quantitative real-time PCR. High RAMP1 expression correlated with poor prognosis relative to low RAMP1 expression (p < 0.05). Low RAMP1 expression correlated with an abundance of CD4 + memory-activated T cells. whereas a high expression level correlated with a high proportion of gamma-delta T cells (γδ T cells). Differentially expressed genes from TARGET was enriched in olfactory transduction pathways (normalized enrichment scores [NES] = 1.6998, p < 0.0001). RAMP1 expression negatively correlated with CD44 expression but positively correlated with TNFSF9 expression. The RAMP1 gene is substantially expressed in OS cells compared to the normal osteoblast cell line hFOB1.19. Thus, RAMP1 may be a prognostic biomarker and potential therapeutic target in OS.